Zhao, Yan
Becce, Fabio
Balmer, Romain
do Amaral, Ricardo H.
Alemán-Gómez, Yasser
Uldry, Emilie
Fraga, Montserrat
Tsoumakidou, Georgia
Villard, Nicolas
Denys, Alban
Digklia, Antonia
Schaefer, Niklaus
Duran, Rafael https://orcid.org/0000-0003-2610-9517
Article History
Received: 7 August 2024
Revised: 5 November 2024
Accepted: 11 December 2024
First Online: 21 January 2025
Compliance with ethical standards
:
: The scientific guarantor of this publication is Dr. Duran Rafael.
: R.D.: Consultant: Guerbet, Boston Scientific/BTG, Medtronic, Terumo. Grant: Guerbet, Boston Scientific/BTG, Society of Interventional Oncology, Siemens Healthineers. AntDi: reports honoraria and/or consulting fees from and has served on advisory boards for F. Hoffmann-La Roche Ltd, Pharmamar, Incyte, Terumo, Boston Scientific/BTG and AstraZeneca. N.V.: Grant: Boston Scientific, Canon Medical. G.T.: honoraria and/or consulting fees from Boston Scientific. The remaining authors declare no conflict of interest.
: No complex statistical methods were necessary for this paper.
: Written informed consent was waived by the Institutional Review Board.
: was obtained from the Institutional Review Board.
: Not applicable.
: